LakeShore Biopharma (NASDAQ:LSB), formerly YS Biopharma, is a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer.
Learn more at lakeshorebio.com.
Learn more at lakeshorebio.com.
Location: China, Beijing
Investors 2
| Date | Name | Website |
| 05.12.2024 | F-Prime Ca... | fprimecapi... |
| 04.03.2025 | Adjuvant C... | adjuvantca... |
Mentions in press and media 2
| Date | Title | Description |
| 23.04.2025 | LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA™ Rabies Vaccine (Vero Cell) | Revolutionizing Vaccination Safety with Needle-Free Reconstitution Technology BEIJING, April 23, 2025 /PRNewswire/ -- On April 18, 2025, LakeShore Biopharma Co., Ltd. (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"... |
| 05.07.2024 | LakeShore Biopharma to Hold an Extraordinary General Meeting on July 25, 2024, Pursuant to Shareholders' Requisition | GAITHERSBURG, Md., July 5, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing,... |